Calendar ·

Calendar

Fr 2010/10/22 - Su 2010/10/24 New benchmarks in leukemia: Focus on CML, AML and MDS The following questions, as well as other complex issues, will be discussed in the programme of the ELN Frontiers Meeting 2010.
− How can basic science and new technologies aid in the optimisation of patient management?
− Are second-generation TKIs suitable for replacing current first-line therapy?
− What is the gold-standard of therapeutic response and what is the best method to assess this?
− How has EUTOS for CML improved patient outcome in Europe?
− Can we translate what we have learned about CML to the treatment of other leukemic disorders?
− What progress have we made in disorders such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)?

The Scientific Programme Committee invites you to submit abstracts for the POSTER SESSION.

Abstract Deadline:2010/08/15

Link: https://events.sannet.ch/eln/default.aspx

Download: application/pdf

ELN_invitationcard_final1st.pdf (1.8 MB)

Place:
Hotel Hilton Vienna
Am Stadtpark 1
1030 Vienna, Austria
Phone: +43 (0)1 71 70 00
Fax: +43 (0)1 71 30 691
Web: www.vienna.hilton.com

Contact:
Dr. Susanne Saussele
Scientific Network Manager
Phone: +49 621 383 6292
Fax: +49 621 383 6969
E-Mail: susanne.saussele@medma.uni-heidelberg.de

[Back]

September 2010 »

European LeukemiaNet